Report Search Results	As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 46) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 22-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (AGN). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (AGN). 5 $18     View Abstract 21-Nov-09 Standard & Poor's STARS Report N/A Allergan, Inc 7 $35     View Abstract 20-Nov-09 New Constructs, LLC N/A AGN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50     View Abstract 20-Nov-09 Pechala's Reports Lubomir Pechala ALLERGAN INC (AGN=US) - REPORT FOR ACTIVE TRADERS 4 $25     View Abstract 20-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AGN , FRX , NVO , SHPGY , WPI -- DRUGS 3 $4     View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALLERGAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ALLERGAN -- AGN 1 $4     View Abstract 19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199     View Abstract Next 20

Brokerage Reports (Showing 1 to 5 of 5) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 30-Oct-09 Thomson StreetEvents N/A AGN - Event Brief of Allergan conference call, Oct. 29, 2009 / 8:00am ET 20 $75     View Abstract 30-Oct-09 Thomson StreetEvents N/A AGN - Event Transcript of Allergan conference call, Oct. 29, 2009 / 8:00am ET 19 $75     View Abstract 29-Oct-09 Collins Stewart LLC Louise Chen 3Q09 In-Line, New Launches and Economic Recovery Will Drive Growth 15 $50     View Abstract 16-Oct-09 Collins Stewart LLC Louise Chen November 2009 Stock Catalysts 22 $75     View Abstract 15-Oct-09 Collins Stewart LLC Louise Chen Key Takeaways From IMS Review of Worldwide Pharma Market in 2010 8 $25     View Abstract

Independent Reports (Showing 1 to 10 of 41) Release Date  Contributor Author Title Pages Price More Info 22-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (AGN). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (AGN). 5 $18 View Abstract 21-Nov-09 Standard & Poor's STARS Report N/A Allergan, Inc 7 $35 View Abstract 20-Nov-09 New Constructs, LLC N/A AGN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50 View Abstract 20-Nov-09 Pechala's Reports Lubomir Pechala ALLERGAN INC (AGN=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract 20-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AGN , FRX , NVO , SHPGY , WPI -- DRUGS 3 $4 View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALLERGAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ALLERGAN -- AGN 1 $4 View Abstract 19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract Next 20